Standard Biotools Price To Book vs. Operating Margin
| LAB Stock | USD 0.93 -0.04 -4.12% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.62 | 0.4986 |
|
|
Profitability analysis for Standard Biotools uses margins and return ratios to relate income to revenue, assets, operating costs, and equity.
Correlation Analysis. Macro event markers
Earnings Share -0.15 | Revenue Per Share | Quarterly Revenue Growth -0.14 | Return On Assets | Return On Equity |
The market value of Standard Biotools is measured differently than book value, which reflects Standard accounting equity. Standard Biotools' market capitalization is 358.65 M. A P/B ratio of 0.84 suggests Standard Biotools trades near or below book value. Enterprise value stands at 201.09 M. Intrinsic value represents an estimate of underlying worth and can differ from both market price and book value. Valuation methods compare these perspectives to frame context.
Note that Standard Biotools' intrinsic value and market price are different measures derived from different inputs. For Standard Biotools, key inputs include a P/B ratio of 0.84, a profit margin of -87.77%, ROE of -13.13%, and revenue of 85.33 M. By contrast, market price reflects the level where buyers and sellers transact.
Standard Biotools Operating Margin vs. Price To Book Fundamental Analysis
Comparative financial modeling measures Standard Biotools's valuation against peer benchmarks. Standard Biotools is rated below average in price to book among leading competitors. It is rated below average in operating margin among leading competitors . Currently, Operating Profit Margin is projected to increase slightly based on multi-year reporting trends. In the prior fiscal year, Operating Profit Margin was reported at -1.0934. Valuation multiples such as P/E, P/B, and P/S compare Standard Biotools to peer earnings performance.Standard Operating Margin vs. Price To Book
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Standard Biotools |
| = | 0.84 X |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Standard Biotools |
| = | -0.29 % |
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Standard Operating Margin Comparison
Standard Biotools is currently under evaluation in operating margin among leading competitors.
Standard Biotools Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Standard Biotools, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Standard Biotools will eventually generate negative long term returns. The profitability progress is the general direction of Standard Biotools' change in net profit over the period of time. It can combine multiple indicators of Standard Biotools, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 1.1 M | 1.2 M | |
| Operating Income | -93.3 M | -88.6 M | |
| Income Before Tax | -96.7 M | -91.9 M | |
| Total Other Income Expense Net | -3.4 M | -3.6 M | |
| Net Loss | -74.9 M | -78.6 M | |
| Income Tax Expense | -37.9 M | -36 M | |
| Interest Income | 23.2 M | 15.6 M | |
| Net Loss | -166.4 M | -158.1 M | |
| Net Interest Income | 19.4 M | 20.4 M | |
| Net Loss | -125 M | -131.2 M | |
| Non Operating Income Net Other | 1.1 M | 1 M | |
| Change To Netincome | 35.3 M | 22.8 M | |
| Net Loss | -0.20 | -0.21 | |
| Income Quality | 0.99 | 0.74 | |
| Net Income Per E B T | 0.77 | 1.07 |
Standard Profitability Driver Comparison
Profitability drivers are factors that directly affect the investment outlook for Standard Biotools. Investors recognize that outcomes may not unfold as predicted, because unforeseen events and market disruptions can arise at any point and significantly alter the earnings trajectory.
Earnings per Share Projection vs Actual
Use Standard Biotools in pair-trading
Pair trading with Standard Biotools can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.
Standard Biotools Pair Trading
Standard Biotools Pair Trading Analysis
The ability to find closely correlated positions to Standard Biotools could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Standard Biotools when you sell it.
The correlation of Standard Biotools is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1.
Correlation analysis and pair trading evaluation for Standard Biotools can be used to frame hedging context. The approach can be applied within sectors or across broader universes.Use Investing Themes to Complement your Standard Biotools position
Using Standard Biotools inside a theme workflow gives investors a structured way to compare related stocks, funds, ETFs, and crypto assets before allocating capital. The practical benefit is that the selected idea can be tuned either for higher upside or for tighter risk control.
Did You Try This Idea?
Run Office Supplies Thematic Idea Now
Office Supplies
Companies producing and selling office supplies, and accessories. The Office Supplies theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Office Supplies Theme or any other thematic opportunities.
| View All Next | Launch |
More Resources for Standard Stock Analysis
A structured review of Standard Biotools often starts with core financial statements and trend context. Key ratios help frame profitability, efficiency, and growth context for Standard Biotools Stock. Outlined below are key reports that provide context for Standard Biotools Stock:Correlation Analysis. For information on how to trade Standard Stock refer to our How to Trade Standard Stock guide.Analysis related to Standard Biotools should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Projecting Standard Biotools' profitability starts with historical financial statements. Core documents include the income statement, balance sheet, and cash-flow statement.